Chapter 8 - DIANE’S CHOICE
Diane asked to speak privately.
We met in my hospital room.
She removed her badge and placed it on the table.
“I may lose my license.”
“Why?”
“I administered medications from the chart.”
“Were they prescribed?”
“I thought they were.”
“That isn’t the whole answer.”
She looked toward the window.
“Twice I noticed pills that looked different from the pharmacy stock.”
“Did you ask?”
“Yes.”
“What did Bridget say?”
“That Dr. Hale had changed suppliers.”
“And Hale?”
“I emailed his office. His assistant confirmed the list.”
“Did you verify with the pharmacy?”
“No.”
“Why?”
“Bridget told me all medication communication had to go through one channel because you were confused by conflicting information.”
I laughed without humor.
“She isolated the nurse from the pharmacy.”
“Yes.”
Diane’s eyes filled.
“I should have broken the chain.”
“You should have.”
She nodded.
No defense.
She had also kept detailed administration logs.
Every pill she personally gave me was documented by time, appearance, and source container.
That record became valuable.
There were days when my symptoms became dramatically worse despite Diane recording no unusual medication.
Those days often occurred when Bridget personally served breakfast or tea.
Diane had unknowingly created evidence separating the official regimen from whatever else happened.
The nursing board opened a review.
She remained licensed under supervision pending investigation.
Accountability did not require pretending good intentions erased missed safeguards.
The estate kitchen inventory showed Bridget sometimes prepared my drinks herself despite house staff normally handling meals.
Alma remembered being ordered out.
“She said Mr. Miles needed privacy.”
“What did you think?”
“I thought she was trying to feel useful.”
Again, ordinary explanations had protected abnormal behavior.
The toxicology lab completed comparison of my blood, urine, orange juice, and residue from the first bottle.
The prosecutor asked that detailed results remain sealed until a second lab confirmed them.
I was told only this:
The juice contained nonfood pharmacological substances.
At least one was not prescribed to me.
The residue in the bottle matched part of the mixture.
My blood contained related compounds.
That was the strongest evidence yet.
Still, we did not know the full pattern, timing, or medical effect.
Dr. Kent said:
“If confirmation holds, we can discuss what these substances likely did.”
I asked whether they caused my paralysis.
“No. Your spinal injury is real.”
The answer mattered.
“Could they have affected recovery?”
“Potentially. We need complete data.”
I was not going to stand up magically because Bridget was arrested.
The injury existed.
The possibility that weakness had been worsened was different.
Police arrested Bridget that evening on expanded charges including assault, evidence tampering, fraud-related conduct, and administration of an unknown substance pending final toxicology classifications.
The charging language remained cautious.
Charles Vane resigned from Vane Health Partners after investigators searched his office.
He had communicated with Bridget about the sale.
He denied knowing anything about medications.
One email supported him:
Keep me out of the medical details. I only need the incapacity certification.
That sentence did not make him innocent.
It suggested roles.
Then detectives found a safe-deposit key in Bridget’s purse.
The box contained unsigned sale papers for Sterling Mobility’s rehabilitation division.
The proposed price was less than half the independent valuation.
Vane Health would buy it.
Bridget would receive a consulting payment worth twelve million dollars after closing.
May you like
The wheelchair was not only a medical object.
It had become part of a transaction.
